Valuation for INM - findataslice
 InMed Pharmaceuticals Inc.
Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014Q1-CY2014Q4-CY2013
Balance Sheet Date2025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312023-Sep-302023-Jun-302023-Mar-312022-Dec-312022-Sep-302022-Jun-302022-Mar-312021-Dec-312021-Sep-302021-Jun-302021-Mar-312020-Dec-312020-Sep-30
Fiscal PeriodQ4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q3-FY2023Q2-FY2023Q1-FY2023Q4-FY2022Q3-FY2022Q2-FY2022Q1-FY2022Q4-FY2021Q3-FY2021Q2-FY2021Q1-FY2021
Close Price of Common Stock2.28$2.22$3.29$2.07$4.56$0.24$0.26$0.36$0.41$0.71$0.93$1.09$2.01$6.62$0.49$0.94$1.34$1.74$3.10$3.31$3.30$
Market Cap of Common Stock5,435,944$5,292,893$3,971,642$2,498,875$3,274,226$3,161,638$2,209,844$2,174,452$2,159,793$2,366,344$3,095,218$3,627,734$1,882,890$6,015,998$7,174,406$13,326,982$18,943,626$16,316,039$24,957,192$23,172,340$23,067,330$
Market Cap of Common Stock QoQ%2.70%33.27%58.94%(23.68%)3.56%43.07%1.63%.68%(8.73%)(23.55%)(14.68%)92.67%(68.70%)(16.15%)(46.17%)(29.65%)16.10%(34.62%)7.70%.46%
Market Cap of Common Stock YoY%66.02%67.41%79.73%14.92%51.60%33.61%(28.61%)(40.06%)14.71%(60.67%)(56.86%)(72.78%)(90.06%)(63.13%)(71.25%)(42.49%)(17.88%)
Common Shares Outstanding2,384,1862,002,1861,207,186724,152666,969445,908317,249283,399166,410166,3703,328,1911,589,992908,766650,66714,283,84814,137,03410,327,034322,0288,050,7077,000,7075,220,7075,220,7075,220,7075,220,7075,220,707
Common Shares Outstanding QoQ%19.08%65.86%66.70%8.57%49.58%40.56%11.94%70.30%.02%(95.00%)109.32%74.96%39.67%(95.45%)1.04%36.89%3,106.88%(96.00%)15.00%34.10%.00%.00%.00%.00%
Common Shares Outstanding YoY%257.47%349.01%280.52%155.52%300.80%168.02%(90.47%)(82.18%)(81.69%)(74.43%)(76.70%)(88.75%)(91.20%)102.05%77.42%101.94%97.81%(93.83%)54.21%34.10%.00%
Total Revenue TTM4,942,633$4,920,990$4,832,013$4,960,506$4,597,730$5,625,728$5,487,052$4,716,635$4,135,561$2,615,574$1,891,234$1,686,543$
Total Revenue1,304,710$1,261,578$1,111,707$1,264,638$1,283,067$1,172,601$1,240,200$901,862$2,311,065$1,033,925$469,783$320,788$791,078$309,585$265,092$880,634$437,309$276,790$
Total Revenue QoQ%3.42%13.48%(12.09%)(1.44%)9.42%(5.45%)37.52%(60.98%)123.52%120.09%46.45%(59.45%)155.53%16.78%101.38%57.99%
Total Revenue YoY%1.69%7.59%(10.36%)40.23%(44.48%)13.41%163.99%181.14%192.14%233.97%77.22%(10.17%)(29.21%)(4.23%)
Gross Margin44.20%13.92%41.46%39.02%36.33%24.69%26.14%2.36%67.95%18.62%27.92%(153.07%)31.57%58.88%42.08%100.00%100.00%100.00%
Earnings to Common Shareholders TTM(8,162,133$)(8,311,493$)(7,913,429$)(6,816,590$)(7,675,550$)(6,076,270$)(6,351,348$)(6,974,250$)(7,947,622$)(15,479,254$)(16,956,975$)(19,138,702$)(18,600,117$)(13,988,847$)(13,614,657$)(11,575,625$)(10,203,089$)(8,560,620$)(7,483,203$)(7,732,916$)(8,939,149$)
Earnings to Common Shareholders(1,788,311$)(2,120,930$)(2,575,024$)(1,677,868$)(1,937,671$)(1,722,866$)(1,478,185$)(2,536,828$)(338,391$)(1,997,944$)(2,101,087$)(3,510,200$)(7,870,023$)(3,475,665$)(4,282,814$)(2,971,615$)(3,258,753$)(3,101,475$)(2,243,782$)(1,599,079$)(1,616,284$)(2,024,058$)(2,493,495$)(2,805,312$)
Earnings to Common Shareholders QoQ%15.68%17.64%(53.47%)13.41%(12.47%)(16.55%)41.73%(649.67%)83.06%4.91%40.14%55.40%(126.43%)18.85%(44.12%)8.81%(5.07%)(38.23%)(40.32%)1.06%20.15%18.83%11.12%
Earnings to Common Shareholders YoY%7.71%(23.11%)(74.20%)33.86%(472.61%)13.77%29.65%27.73%95.70%42.52%50.94%(18.12%)(141.50%)(12.07%)(90.88%)(85.83%)(101.62%)(53.23%)10.02%43.00%
Profit Margin(137.07%)(168.12%)(231.63%)(132.68%)(151.02%)(146.93%)(119.19%)(281.29%)(14.64%)(193.24%)(447.25%)(1,094.24%)(994.85%)(1,122.69%)(1,615.60%)(370.05%)(709.22%)(810.64%)
Equity to Common Shareholders13,434,495$7,021,525$6,182,100$8,395,444$9,206,109$11,104,650$12,772,211$(9,578,090$)12,089,727$12,387,638$14,335,051$11,007,940$9,078,541$10,886,733$14,167,313$15,221,672$7,376,567$10,414,470$7,590,813$4,494,046$5,878,318$7,072,509$9,610,208$11,469,595$
Equity to Common Shareholders QoQ6,412,970$839,425$(2,213,344$)(810,665$)(1,898,541$)(1,667,561$)22,350,301$(21,667,817$)(297,911$)(1,947,413$)3,327,111$1,929,399$(1,808,192$)(3,280,580$)(1,054,359$)7,845,105$(3,037,903$)2,823,657$3,096,767$(1,384,272$)(1,194,191$)(2,537,699$)(1,859,387$)
Equity to Common Shareholders QoQ%91.33%13.58%(26.36%)(8.81%)(17.10%)(13.06%)233.35%(179.23%)(2.41%)(13.59%)30.23%21.25%(16.61%)(23.16%)(6.93%)106.35%(29.17%)37.20%68.91%(23.55%)(16.89%)(26.41%)(16.21%)
Equity to Common Shareholders YoY4,228,386$(4,083,125$)(6,590,111$)17,973,534$(2,883,618$)(1,282,988$)(1,562,840$)(20,586,030$)3,011,186$1,500,905$167,738$(4,213,732$)1,701,974$472,263$6,576,500$10,727,626$1,498,249$3,341,961$(2,019,395$)(6,975,549$)
Equity to Common Shareholders YoY%45.93%(36.77%)(51.60%)187.65%(23.85%)(10.36%)(10.90%)(187.01%)33.17%13.79%1.18%(27.68%)23.07%4.54%86.64%238.71%25.49%47.25%(21.01%)(60.82%)
Dividends Paid
Additional Paid-In Capital QoQ40,480$(2,707,297$)3,237,166$3,486,668$5,168,701$(533,645$)(2,181,422$)7,717,413$220,850$3,345,827$96,634$85,407$
Treasury Stock
Treasury Stock QoQ
Price to Sales1.10x1.07x.80x.51x.68x.64x.48x.39x.39x.50x.75x1.39x1.00x3.57x
Price to Earnings---------------------
Price to Book.40x.39x.30x.36x.53x.38x.24x.20x.17x-.26x.29x.13x.55x.79x1.22x1.34x1.07x3.38x2.23x3.04x
Goodwill2,023,039$2,023,039$
Goodwill QoQ%.00%
Goodwill YoY%
Other Intangible Assets1,620,562$1,661,109$1,701,211$1,742,205$1,783,198$1,823,745$1,864,292$1,905,286$1,946,279$1,986,826$2,026,929$2,067,922$2,108,915$2,355,401$2,400,831$1,037,382$1,061,697$1,085,748$1,109,535$1,088,630$1,086,655$
Other Intangible Assets QoQ(40,547$)(40,102$)(40,994$)(40,993$)(40,547$)(40,547$)(40,994$)(40,993$)(40,547$)(40,103$)(40,993$)(40,993$)(246,486$)(45,430$)1,363,449$(24,315$)(24,051$)(23,787$)20,905$1,975$
Amortization of Intangible Assets40,547$40,103$42,820$40,993$49,327$40,993$40,993$40,993$37,139$40,103$40,993$40,993$45,932$45,430$43,551$24,315$24,051$23,788$30,288$21,597$20,785$21,391$21,983$23,446$
Forward Price to Sales MRQ1.04x1.01x.76x.50x.74x.63x.43x.46x.44x.66x.33x.88x1.00x4.69x2.27x10.76x17.87x4.63x7.09x13.25x20.83x
Forward Price to Earnings MRQ---------------------
Total Assets15,580,040$9,279,834$8,502,292$10,465,106$11,822,782$13,358,716$15,255,464$10,917,339$14,106,340$14,730,101$16,919,696$14,584,330$12,787,580$15,485,797$19,383,720$17,327,264$9,781,216$12,344,999$11,747,422$6,603,674$7,802,597$
Total Assets QoQ6,300,206$777,542$(1,962,814$)(1,357,676$)(1,535,934$)(1,896,748$)4,338,125$(3,189,001$)(623,761$)(2,189,595$)2,335,366$1,796,750$(2,698,217$)(3,897,923$)2,056,456$7,546,048$(2,563,783$)597,577$5,143,748$(1,198,923$)
Total Assets YoY3,757,258$(4,078,882$)(6,753,172$)(452,233$)(2,283,558$)(1,371,385$)(1,664,232$)(3,666,991$)1,318,760$(755,696$)(2,464,024$)(2,742,934$)3,006,364$3,140,798$7,636,298$10,723,590$1,978,619$
Total Liabilities2,145,545$2,258,309$2,320,192$2,069,662$2,616,673$2,254,066$2,483,253$1,339,249$2,016,613$2,342,463$2,584,645$3,576,390$3,709,039$4,599,064$5,216,407$2,105,592$2,404,649$1,930,529$4,156,609$2,109,628$1,924,279$
Total Liabilities QoQ(112,764$)(61,883$)250,530$(547,011$)362,607$(229,187$)1,144,004$(677,364$)(325,850$)(242,182$)(991,745$)(132,649$)(890,025$)(617,343$)3,110,815$(299,057$)474,120$(2,226,080$)2,046,981$185,349$
Total Liabilities YoY(471,128$)4,243$(163,061$)730,413$600,060$(88,397$)(101,392$)(2,237,141$)(1,692,426$)(2,256,601$)(2,631,762$)1,470,798$1,304,390$2,668,535$1,059,798$(4,036$)480,370$
Current Ratio6.99x3.49x3.05x5.07x4.41x6.58x7.03x6.19x5.66x5.22x5.84x3.52x2.89x2.13x2.71x8.29x3.78x6.36x4.76x2.73x3.77x
Total Current Assets12,867,279$6,410,063$5,470,120$7,279,892$8,689,585$10,064,002$11,810,070$8,295,208$11,331,727$11,842,545$14,017,715$11,542,909$9,597,776$8,746,886$12,505,026$15,976,323$8,378,269$10,896,704$10,249,388$5,116,527$6,312,457$
Total Current Assets QoQ6,457,216$939,943$(1,809,772$)(1,409,693$)(1,374,417$)(1,746,068$)3,514,862$(3,036,519$)(510,818$)(2,175,170$)2,474,806$1,945,133$850,890$(3,758,140$)(3,471,297$)7,598,054$(2,518,435$)647,316$5,132,861$(1,195,930$)
Total Current Liabilities1,839,790$1,838,962$1,790,944$1,435,879$1,971,808$1,528,830$1,680,469$1,339,249$2,000,619$2,269,669$2,400,743$3,282,053$3,319,541$4,105,502$4,617,765$1,927,001$2,215,361$1,714,295$2,153,637$1,874,030$1,676,268$
Total Current Liabilities QoQ828$48,018$355,065$(535,929$)442,978$(151,639$)341,220$(661,370$)(269,050$)(131,074$)(881,310$)(37,488$)(785,961$)(512,263$)2,690,764$(288,360$)501,066$(439,342$)279,607$197,762$
Debt to Asset Ratio.14x.24x.27x.20x.22x.17x.16x.12x.14x.16x.15x.25x.29x.30x.27x.12x.25x.16x.35x.32x.25x
Long Term Debt
Long Term Debt QoQ
Long Term Debt YoY
Capital Lease Obligations741,262$848,594$948,959$1,058,043$962,662$1,070,781$1,166,974$292,998$391,707$825,427$825,427$825,427$385,057$385,057$385,057$385,057$385,057$
Interest Expenses1,500$3,000$6,800$0$0$360,350$
Cash and Cash Equivalents11,075,871$4,679,826$3,419,422$5,583,039$6,571,610$7,600,598$9,534,922$6,738,304$8,912,517$9,604,057$11,452,578$9,350,427$6,176,866$5,898,313$11,279,964$15,343,905$7,363,126$9,454,113$10,020,853$4,497,296$5,805,809$
Cash and Cash Equivalents QoQ6,396,045$1,260,404$(2,163,617$)(988,571$)(1,028,988$)(1,934,324$)2,796,618$(2,174,213$)(691,540$)(1,848,521$)2,102,151$3,173,561$278,553$(5,381,651$)(4,063,941$)7,980,779$(2,090,987$)(566,740$)5,523,557$(1,308,513$)
Cash and Cash Equivalents YoY4,504,261$(2,920,772$)(6,115,500$)(1,155,265$)(2,340,907$)(2,003,459$)(1,917,656$)(2,612,123$)2,735,651$3,705,744$172,614$(5,993,478$)(1,186,260$)(3,555,800$)1,259,111$10,846,609$1,557,317$
Interest Income51,687$16,565$30,536$57,094$103,640$121,458$166,760$136,043$148,559$155,497$115,797$72,587$33,701$30,964$26,277$5,148$4,825$3,797$3,050$4,345$4,295$26,330$40,495$58,406$